Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2025-12-16 @ 8:52 PM
Study NCT ID:
NCT06374602
Status:
None
Last Update Posted:
2025-09-05 00:00:00
First Post:
2024-03-27 00:00:00
Brief Title:
Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Sponsor:
Saint Petersburg State University Russia
Organization:
Saint Petersburg State University, Russia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-25
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-27 00:00:00
First Submit QC Date:
April 16 2024
Study First Post Date:
2024-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-29 00:00:00
Last Update Post Date:
2025-09-05 00:00:00
Last Update Post Date Type:
ESTIMATED